PATENT CLAIM ANALYSIS

Application Number: 16139793
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-02
Patent Classification: ["424", "465000"]

Abstract:
Controlled release and taste masking compositions containing one or more active principles inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrophilic matrices. The use of a plurality of systems for the control of the dissolution of the active ingredient modulates the dissolution rate of the active ingredient in aqueous and/or biological fluids, thereby controlling the release kinetics in the gastrointestinal tract.

Claim (Index 24):
The tablet of  claim 7 , wherein following oral administration of the tablet to a human, the tablet provides a T max  of said budesonide in said human of about 13.3\u00b15.9 hours.

Metadata:
- Claim Count in Document: 82.0
- Percentile: 97.0
- Lexical Diversity: 1.57692
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16132789', '16034664', '15202962', '13585190', '14491363']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8064798333069665
- 35 USC 102 Novelty (BERT): 0.5847753547600957
- Combined Prediction Score: 0.7843093854522794
- Mean Citation Score: 457.792536
- Max Citation Score: 505.62796
- Similarity Product: 491.9641558713008

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test